BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kane MA, Elwood PC, Portillo RM, Antony AC, Najfeld V, Finley A, Waxman S, Kolhouse JF. Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human cells. J Clin Invest 1988;81:1398-406. [PMID: 3366900 DOI: 10.1172/JCI113469] [Cited by in Crossref: 71] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Chung KN, Saikawa Y, Paik TH, Dixon KH, Mulligan T, Cowan KH, Elwood PC. Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates. J Clin Invest 1993;91:1289-94. [PMID: 7682567 DOI: 10.1172/JCI116327] [Cited by in Crossref: 56] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
2 Saw PE, Song EW. Phage display screening of therapeutic peptide for cancer targeting and therapy. Protein Cell 2019;10:787-807. [PMID: 31140150 DOI: 10.1007/s13238-019-0639-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
3 Jhaveri MS, Rait AS, Chung K, Trepel JB, Chang EH. Antisense oligonucleotides targeted to the human α folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment. Molecular Cancer Therapeutics 2004;3:1505-12. [DOI: 10.1158/1535-7163.1505.3.12] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
4 Antony A, Tang YS, Khan RA, Biju MP, Xiao X, Li QJ, Sun XL, Jayaram HN, Stabler SP. Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions. J Clin Invest 2004;113:285-301. [PMID: 14722620 DOI: 10.1172/JCI11548] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
5 Chen YL, Chang MC, Huang CY, Chiang YC, Lin HW, Chen CA, Hsieh CY, Cheng WF. Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response. Mol Oncol 2012;6:360-9. [PMID: 22265591 DOI: 10.1016/j.molonc.2011.11.010] [Reference Citation Analysis]
6 Basal E, Eghbali-Fatourechi GZ, Kalli KR, Hartmann LC, Goodman KM, Goode EL, Kamen BA, Low PS, Knutson KL. Functional folate receptor alpha is elevated in the blood of ovarian cancer patients. PLoS One 2009;4:e6292. [PMID: 19617914 DOI: 10.1371/journal.pone.0006292] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Viel A, Dall'Agnese L, Simone F, Canzonieri V, Capozzi E, Visentin MC, Valle R, Boiocchi M. Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer 1997;75:1105-10. [PMID: 9099956 DOI: 10.1038/bjc.1997.191] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 1.9] [Reference Citation Analysis]
8 Antony AC, Briddell RA, Brandt JE, Straneva JE, Verma RS, Miller ME, Kalasinski LA, Hoffman R. Megaloblastic hematopoiesis in vitro. Interaction of anti-folate receptor antibodies with hematopoietic progenitor cells leads to a proliferative response independent of megaloblastic changes. J Clin Invest 1991;87:313-25. [PMID: 1702099 DOI: 10.1172/JCI114989] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
9 Jia L, Li J, Li P, Liu D, Li J, Shen J, Zhu B, Ma C, Zhao T, Lan R, Dang L, Li W, Sun S. Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT. Theranostics 2021;11:6905-21. [PMID: 34093861 DOI: 10.7150/thno.56882] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
10 Jaime-Ramirez AC, McMichael E, Kondadasula S, Skinner CC, Mundy-Bosse BL, Luedke E, Jones NB, Mani A, Roda J, Karpa V, Li H, Li J, Elavazhagan S, La Perle KM, Schmitt AC, Lu Y, Zhang X, Pan X, Mao H, Davis M, Jarjoura D, Butchar JP, Poi M, Phelps M, Tridandapani S, Byrd JC, Caligiuri MA, Lee RJ, Carson WE 3rd. NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines. Cancer Immunol Res 2016;4:323-36. [PMID: 26865456 DOI: 10.1158/2326-6066.CIR-15-0168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Kronenberg G, Endres M. Neuronal injury: folate to the rescue? J Clin Invest 2010;120:1383-6. [PMID: 20424316 DOI: 10.1172/JCI40764] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
12 Nakagawa F, Kawashima H, Morita T, Nakamura H. Water-Soluble closo-Docecaborate-Containing Pteroyl Derivatives Targeting Folate Receptor-Positive Tumors for Boron Neutron Capture Therapy. Cells 2020;9:E1615. [PMID: 32635272 DOI: 10.3390/cells9071615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Sun XL, Murphy BR, Li QJ, Gullapalli S, Mackins J, Jayaram HN, Srivastava A, Antony AC. Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo. J Clin Invest 1995;96:1535-47. [PMID: 7657824 DOI: 10.1172/JCI118192] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kelemen LE, Brenton JD, Parkinson C, C Whitaker H, Piskorz AM, Csizmadi I, Robson PJ. Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women. PLoS One 2014;9:e96542. [PMID: 24810481 DOI: 10.1371/journal.pone.0096542] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
15 Basal E, Eghbali-Fatourechi GZ, Kalli KR, Hartmann LC, Goodman KM, Goode EL, Kamen BA, Low PS, Knutson KL. Functional folate receptor alpha is elevated in the blood of ovarian cancer patients. PLoS One 2009;4:e6292. [PMID: 19617914 DOI: 10.1371/journal.pone.0006292] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
16 Alkan D, Guven B, Turer CC, Balli U, Can M. Folate-receptor 1 level in periodontal disease: a pilot study. BMC Oral Health 2019;19:218. [PMID: 31604439 DOI: 10.1186/s12903-019-0909-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Ottone F, Miotti S, Bottini C, Bagnoli M, Perego P, Colnaghi MI, Ménard S. Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines. Br J Cancer 1997;76:77-82. [PMID: 9218736 DOI: 10.1038/bjc.1997.339] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
18 Mohanty V, Siddiqui MR, Tomita T, Mayanil CS. Folate receptor alpha is more than just a folate transporter. Neurogenesis 2017;4:e1263717. [DOI: 10.1080/23262133.2016.1263717] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
19 Huang Y, Meng L, Nie Q, Zhou Y, Chen L, Yang S, Fung YME, Li X, Huang C, Cao Y, Li Y, Li X. Selection of DNA-encoded chemical libraries against endogenous membrane proteins on live cells. Nat Chem 2021;13:77-88. [PMID: 33349694 DOI: 10.1038/s41557-020-00605-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
20 Verma RS, Antony AC. Immunoreactive folate-binding proteins from human saliva. Isolation and comparison of two distinct species. Biochem J 1992;286 ( Pt 3):707-15. [PMID: 1417729 DOI: 10.1042/bj2860707] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
21 Köbel M, Madore J, Ramus SJ, Clarke BA, Pharoah PD, Deen S, Bowtell DD, Odunsi K, Menon U, Morrison C, Lele S, Bshara W, Sucheston L, Beckmann MW, Hein A, Thiel FC, Hartmann A, Wachter DL, Anglesio MS, Høgdall E, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Fogarty ZC, Vierkant RA, Liu S, Cho S, Nelson G, Ghatage P, Gentry-Maharaj A, Gayther SA, Benjamin E, Widschwendter M, Intermaggio MP, Rosen B, Bernardini MQ, Mackay H, Oza A, Shaw P, Jimenez-Linan M, Driver KE, Alsop J, Mack M, Koziak JM, Steed H, Ewanowich C, DeFazio A, Chenevix-Trench G, Fereday S, Gao B, Johnatty SE, George J, Galletta L, Goode EL, Kjær SK, Huntsman DG, Fasching PA, Moysich KB, Brenton JD, Kelemen LE; AOCS Study Group. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study. Br J Cancer 2014;111:2297-307. [PMID: 25349970 DOI: 10.1038/bjc.2014.567] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
22 Köbel M, Madore J, Ramus SJ, Clarke BA, Pharoah PD, Deen S, Bowtell DD, Odunsi K, Menon U, Morrison C, Lele S, Bshara W, Sucheston L, Beckmann MW, Hein A, Thiel FC, Hartmann A, Wachter DL, Anglesio MS, Høgdall E, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Fogarty ZC, Vierkant RA, Liu S, Cho S, Nelson G, Ghatage P, Gentry-Maharaj A, Gayther SA, Benjamin E, Widschwendter M, Intermaggio MP, Rosen B, Bernardini MQ, Mackay H, Oza A, Shaw P, Jimenez-Linan M, Driver KE, Alsop J, Mack M, Koziak JM, Steed H, Ewanowich C, DeFazio A, Chenevix-Trench G, Fereday S, Gao B, Johnatty SE, George J, Galletta L, Goode EL, Kjær SK, Huntsman DG, Fasching PA, Moysich KB, Brenton JD, Kelemen LE; AOCS Study Group. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study. Br J Cancer 2014;111:2297-307. [PMID: 25349970 DOI: 10.1038/bjc.2014.567] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Skinner CC, McMichael EL, Jaime-Ramirez AC, Abrams ZB, Lee RJ, Carson WE 3rd. Folate-conjugated immunoglobulin targets melanoma tumor cells for NK cell effector functions. Melanoma Res 2016;26:329-37. [PMID: 27035691 DOI: 10.1097/CMR.0000000000000258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
24 Antony AC, Kane MA, Krishnan SR, Kincade RS, Verma RS. Folate (pteroylglutamate) uptake in human red blood cells, erythroid precursors and KB cells at high extracellular folate concentrations. Evidence against a role for specific folate-binding and transport proteins. Biochem J 1989;260:401-11. [PMID: 2548476 DOI: 10.1042/bj2600401] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
25 Alnabbat KI, Fardous AM, Cabelof DC, Heydari AR. Excessive Folic Acid Mimics Folate Deficiency in Human Lymphocytes. CIMB 2022;44:1452-62. [DOI: 10.3390/cimb44040097] [Reference Citation Analysis]
26 Kamen BA, Johnson CA, Wang MT, Anderson RG. Regulation of the cytoplasmic accumulation of 5-methyltetrahydrofolate in MA104 cells is independent of folate receptor regulation. J Clin Invest 1989;84:1379-86. [PMID: 2478584 DOI: 10.1172/JCI114310] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
27 Liu G, Jiang Z, Lovell JF, Zhang L, Zhang Y. Design of a Thiol-Responsive, Traceless Prodrug with Rapid Self-Immolation for Cancer Chemotherapy. ACS Appl Bio Mater 2021;4:4982-9. [PMID: 35007046 DOI: 10.1021/acsabm.1c00247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
28 Chen YL, Chang MC, Huang CY, Chiang YC, Lin HW, Chen CA, Hsieh CY, Cheng WF. Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response. Mol Oncol 2012;6:360-9. [PMID: 22265591 DOI: 10.1016/j.molonc.2011.11.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Xing L, Xu Y, Sun K, Wang H, Zhang F, Zhou Z, Zhang J, Zhang F, Caliskan B, Qiu Z, Wang M. Identification of a peptide for folate receptor alpha by phage display and its tumor targeting activity in ovary cancer xenograft. Sci Rep 2018;8:8426. [PMID: 29849110 DOI: 10.1038/s41598-018-26683-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
30 Chen YL, Chang MC, Huang CY, Chiang YC, Lin HW, Chen CA, Hsieh CY, Cheng WF. Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response. Mol Oncol 2012;6:360-9. [PMID: 22265591 DOI: 10.1016/j.molonc.2011.11.010] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
31 Chen C, Ke J, Zhou XE, Yi W, Brunzelle JS, Li J, Yong EL, Xu HE, Melcher K. Structural basis for molecular recognition of folic acid by folate receptors. Nature 2013;500:486-9. [PMID: 23851396 DOI: 10.1038/nature12327] [Cited by in Crossref: 374] [Cited by in F6Publishing: 334] [Article Influence: 41.6] [Reference Citation Analysis]
32 Somers EB, O'Shannessy DJ. Folate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease. Biomark Insights 2014;9:29-37. [PMID: 24932099 DOI: 10.4137/BMI.S15245] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
33 Erba E, Sen S, Sessa C, Vikhanskaya FL, D'Incalci M. Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid. Br J Cancer 1994;69:205-11. [PMID: 8297715 DOI: 10.1038/bjc.1994.40] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]